YA II PN, Ltd. - Dec 13, 2024 SCHEDULE 13G Report for InMed Pharmaceuticals Inc. Common Shares (INM)

Filing Manager
YA II PN, Ltd.
Reporting Manager
YA II PN, Ltd.
Security
InMed Pharmaceuticals Inc. Common Shares
Symbol
INM
Shares outstanding
805K shares
Disclosed Ownership
80.4K shares
Ownership
9.99%
Form type
SCHEDULE 13G
Date filed
12/18/2024, 08:05 AM
Date of event
Dec 13, 2024
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
YA II PN, Ltd. 9.99% 80.4K 0 80.4K /s/ David Gonzalez David Gonzalez, General Counsel
YA Global Investments II (U.S.), LP 9.99% 80.4K 0 80.4K /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global, LP 9.99% 80.4K 0 80.4K /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global II, LLC 9.99% 80.4K 0 80.4K /s/ David Gonzalez David Gonzalez, General Counsel
YA II GP, LP 9.99% 80.4K 0 80.4K /s/ David Gonzalez David Gonzalez, General Counsel
YAII GP II, LLC 9.99% 80.4K 0 80.4K /s/ David Gonzalez David Gonzalez, General Counsel
Mark Angelo 9.99% 80.4K 0 80.4K /s/ Mark Angelo Mark Angelo
SC-Sigma Global Partners, LP 9.99% 80.4K 0 80.4K /s/ David Gonzalez David Gonzalez, General Counsel